STRATA Skin Sciences sues LaserOptek, MLS, Pinnacle for false advertising of Pallas lasers

STRATA Skin Sciences, Inc.

Filed complaint in U.S. District Court for Eastern District of Pennsylvania alleging unfair competition and false advertising under Lanham Act.
Claims defendants misrepresented that Pallas lasers qualify for CMS reimbursement codes reserved for excimer lasers like STRATA's XTRAC.
Also alleges false statements of technological and clinical equivalence without scientific evidence, causing harm to competition and patients.
Seeks injunctive relief, actual and treble damages, disgorgement of profits, and legal costs from LaserOptek, MLS, and Pinnacle.
Defendants include Korean manufacturer LaserOptek (KOSDAQ), its U.S. distributor Monarch Laser Services, and advisor Pinnacle Health Group.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.